Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

1333 – Study On The Incidence Of Depression And Apathy In a Group Of Patients Diagnosed With Parkinson’s Disease

View through CrossRef
IntroductionDepression and apathy are among the most common psychiatric and behavioral disorders associated with Parkinson’s disease (PD). This two psychiatric disorders are major determinants of quality of life for patients with Parkinson’s disease.ObjectivesThe main objective of this study was to establish the prevalence and demographic and clinical correlates of depression and apathy in a sample of inpatients with Parkinson’s disease.AimsTo identify depression and apathy in a group of patients diagnosed with Parkinson’s disease and to allow appropriate treatment to improve their quality of life.MethodsA number of 44 inpatients with Parkinson’s disease were investigated with the Starkstein’s Apathy Scale (AS), the 17-item Hamilton Depression Rating Scale (HDRS-17), the Hoehn and Yahr staging (HY), the Unified Parkinson’s Disease Rating Scale (UPDRS) and the Mini -Mental State Examination (MMSE).ResultsApathy coexisted with depression in 34.1% of PD patients, compared with depression without apathy in 4.6%, and apathy without depression in 22.7%. Apathy was associated with higher UPDRS score, lower MMSE score and earlier HY stages. Depression was correlated with more advanced HY stages and younger age of patients with Parkinson’s disease.ConclusionsApathy and depression are common in patients with Parkinson’s disease. Therefore these two conditions should be screened and considered in the management of patients with Parkinson’s disease.
Title: 1333 – Study On The Incidence Of Depression And Apathy In a Group Of Patients Diagnosed With Parkinson’s Disease
Description:
IntroductionDepression and apathy are among the most common psychiatric and behavioral disorders associated with Parkinson’s disease (PD).
This two psychiatric disorders are major determinants of quality of life for patients with Parkinson’s disease.
ObjectivesThe main objective of this study was to establish the prevalence and demographic and clinical correlates of depression and apathy in a sample of inpatients with Parkinson’s disease.
AimsTo identify depression and apathy in a group of patients diagnosed with Parkinson’s disease and to allow appropriate treatment to improve their quality of life.
MethodsA number of 44 inpatients with Parkinson’s disease were investigated with the Starkstein’s Apathy Scale (AS), the 17-item Hamilton Depression Rating Scale (HDRS-17), the Hoehn and Yahr staging (HY), the Unified Parkinson’s Disease Rating Scale (UPDRS) and the Mini -Mental State Examination (MMSE).
ResultsApathy coexisted with depression in 34.
1% of PD patients, compared with depression without apathy in 4.
6%, and apathy without depression in 22.
7%.
Apathy was associated with higher UPDRS score, lower MMSE score and earlier HY stages.
Depression was correlated with more advanced HY stages and younger age of patients with Parkinson’s disease.
ConclusionsApathy and depression are common in patients with Parkinson’s disease.
Therefore these two conditions should be screened and considered in the management of patients with Parkinson’s disease.

Related Results

Stress-related mental disorders : an exploration astrocytic biomarkers, comorbidities, and cognition
Stress-related mental disorders : an exploration astrocytic biomarkers, comorbidities, and cognition
<p dir="ltr">Background</p><p dir="ltr">Prolonged exposure to stressors without sufficient recovery can lead to physical and mental symptoms. In Sweden, individua...
Stress-related mental disorders : an exploration astrocytic biomarkers, comorbidities, and cognition
Stress-related mental disorders : an exploration astrocytic biomarkers, comorbidities, and cognition
<p dir="ltr">Background</p><p dir="ltr">Prolonged exposure to stressors without sufficient recovery can lead to physical and mental symptoms. In Sweden, individua...
MBI‐apathy, ApoEɛ2, and risk for Alzheimer disease dementia
MBI‐apathy, ApoEɛ2, and risk for Alzheimer disease dementia
AbstractBackgroundApathy, characterized by decreased interest, initiative, and emotional reactivity, is amongst the most common neuropsychiatric symptoms in dementia. However, apat...
Apathy in Parkinson’s Disease: Defining the Park Apathy Subtype
Apathy in Parkinson’s Disease: Defining the Park Apathy Subtype
Apathy is a neurobehavioural symptom affecting Parkinson’s disease patients of all disease stages. Apathy seems to be associated with a specific underlying non-motor disease subtyp...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract Introduction Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Incidence and associated risk factors of nontuberculous mycobacterial infection in patients with depression
Incidence and associated risk factors of nontuberculous mycobacterial infection in patients with depression
Background It has been reported that the risk of mental health problems such as anxiety or depression increases in patients with nontuberculous mycobacterial (NTM) infection. Howev...
Parkinson’s disease and depression
Parkinson’s disease and depression
Introduction Parkinson’s disease has long been considered as a neurodegenerative disorder of pure motor expression. Motor dysfunction in Parkinson’s disease and other parkinsonian ...
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract Introduction  Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...

Back to Top